Adamas Pharmaceuticals
ADMS
#7199
Rank
ยฃ0.28 B
Marketcap
ยฃ6.17
Share price
0.00%
Change (1 day)
15,285.31%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): ยฃ64.62 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is ยฃ66.23 Million. In 2020 the company made a revenue of ยฃ55.92 Million an increase over the revenue in the year 2019 that were of ยฃ41.03 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ64.62 M15.54%
2020ยฃ55.92 M36.28%
2019ยฃ41.03 M60.48%
2018ยฃ25.57 M
2016ยฃ0.42 M-70.15%
2015ยฃ1.43 M-96.57%
2014ยฃ41.94 M-21.45%
2013ยฃ53.4 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ61.35 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.49 B 650.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.31 B 63,778.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.18 B 45,461.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ48.19 B 72,661.91%๐Ÿ‡บ๐Ÿ‡ธ USA